Last reviewed 2026-04-23 · How we verify

ESL Banana taste

Bial - Portela C S.A. · Phase 2 active Small molecule

ESL Banana taste is a Small molecule drug developed by Bial - Portela C S.A.. It is currently in Phase 2 development. Also known as: Eslicarbazepine acetate (ESL).

At a glance

Generic name	ESL Banana taste
Also known as	Eslicarbazepine acetate (ESL)
Sponsor	Bial - Portela C S.A.
Modality	Small molecule
Phase	Phase 2

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Double-blind Study in Paediatric Epileptic to Compare the Subject Preference for ESL Suspension Formulation With Alternative Flavours (PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

ESL Banana taste CI brief — competitive landscape report
ESL Banana taste updates RSS · CI watch RSS
Bial - Portela C S.A. portfolio CI

Frequently asked questions about ESL Banana taste

What is ESL Banana taste?

ESL Banana taste is a Small molecule drug developed by Bial - Portela C S.A..

Who makes ESL Banana taste?

ESL Banana taste is developed by Bial - Portela C S.A. (see full Bial - Portela C S.A. pipeline at /company/bial-portela-c-s-a).

Is ESL Banana taste also known as anything else?

ESL Banana taste is also known as Eslicarbazepine acetate (ESL).

What development phase is ESL Banana taste in?

ESL Banana taste is in Phase 2.

Manufacturer: Bial - Portela C S.A. — full pipeline
Also known as: Eslicarbazepine acetate (ESL)
Compare: ESL Banana taste vs similar drugs
Pricing: ESL Banana taste cost, discount & access